1. Home
  2. Labeler Index
  3. Remedyrepack Inc.
  4. 70518-1334
  5. Product Images: Spironolactone

Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Spironolactone NDC 70518-1334 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy Label

Remedy Label

This is a description of Spironolactone 100mg tablet. The package contains 100 tablets and it is RX only. The drug is manufactured by Accord Healthcare, Inc. The lot number and the source NDC are provided, but the expiry date is not available. There are directions for use in the package insert. The drug should be stored at temperatures between 20-25°C (88-77°F), with excursions permitted up to 15-30°C (59-86°F). The packaging was done by RemedyRepack Inc., Indiana, PA 15701.*

MM3 - Spironolactone 100mg 70518 1334 02

MM3 - Spironolactone 100mg 70518 1334 02

This is a description of Spironolactone 100mg tablet, a prescription medication by Accord Healthcare. The tablet is packed by RemedyRepack Inc. and has an NDC (National Drug Code) number 70518-1334-02. The medication is meant for oral consumption and comes with usage instructions which can be found in the package insert. The medication should be stored at 20-25°C (88-77°F) with excursions permitted o 15-30°C (59-86°F) [See USP]. The LOT number is not available.*

Figure 1 - spironolactone figure 1

Figure 1 - spironolactone figure 1

This appears to be a statistical output, specifically related to survival analysis. The text mentions the log-rank p-value, which is a statistical test used to compare the survival curves of two or more groups. The value is shown as being less than 0.001, indicating a strong level of significance. The other text shows a series of time intervals, measured in months, which may correspond to the length of time over which the survival analysis was conducted. However, without additional context, it's impossible to say for certain.*

Figure 2 - spironolactone figure 2

Figure 2 - spironolactone figure 2

This appears to be a graph or chart depicting the results of a study comparing the effectiveness of Spironolactone and a Placebo treatment for a particular condition. The x-axis shows the dosage levels, while the y-axis appears to represent the efficacy of each treatment based on the subgroups studied. However, without further context or information, it is difficult to provide a more specific description.*

Chemical Structure - spironolactone structure image

Chemical Structure - spironolactone structure image

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.